NCT06737341View on ClinicalTrials.gov

Bupivacaine Liposomes or Bupivacaine for CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions
BupivacaineUltrasound-GuidedAnalgesia, PostoperativeOpioids
Interventions
DRUG

Bupivacaine Liposomes(BL)

20ml of bupivacaine liposomes (266mg) + 10 ml of bupivacaine 0.75% hydrochloride + 20ml saline for ultrasound guided CMB.

DRUG

Bupivacaine(B)

10 ml of 0.75% bupivacaine hydrochloride + 40ml normal saline for ultrasound-guided bilateral costal margin block

Trial Locations (1)

430030

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. 1095 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER